Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Can Broadly Neutralizing Monoclonal Antibodies Lead to a Hepatitis C Virus Vaccine?

Trends in microbiology - 1 Oct 2018

Kinchen Valerie J, Cox Andrea L, Bailey Justin R

Abstract excerpt

While licensed vaccines elicit protective antibody responses against a variety of viral infections, an effective vaccine for hepatitis C virus (HCV) has remained elusive. The extraordinary genetic diversity of HCV and the ability of the virus to evade the immune response have hindered vaccine development efforts. However, recent studies have greatly expanded the number of well characterized broadly neutralizing...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies, Neutralizing
Share to Antibodies, Viral
Share to Antigen-Antibody Complex

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Epitope Mapping

Share to Epitopes

Share to Haplorhini

Share to Hepatitis C

Share to Viral Hepatitis Vaccines

Source

Open in PubMed Open full text

Identifiers

PMID: 29703495
DOI: 10.1016/j.tim.2018.04.002
PMCID: PMC6421862

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Can Broadly Neutralizing Monoclonal Antibodies Lead to a Hepatitis C Virus Vaccine?PMID 29703495Read ↗

Viral evasion and challenges of hepatitis C virus vaccine development.Semantic proximity Read ↗

Signatures of VH1-69-derived hepatitis C virus neutralizing antibody precursors defined by binding to envelope glycoproteinsSemantic proximity Read ↗

From Structural Studies to HCV Vaccine Design.Semantic proximity Read ↗

Genetic and structural insights into broad neutralization of hepatitis C virus by human V H 1-69 antibodiesSemantic proximity Read ↗

Immunogenetic and structural analysis of a class of HCV broadly neutralizing antibodies and their precursorsSemantic proximity Read ↗

Human broadly neutralizing antibodies to the envelope glycoprotein complex of hepatitis C virus.Semantic proximity Read ↗

A Diverse Panel of Hepatitis C Virus Glycoproteins for Use in Vaccine Research Reveals Extremes of Monoclonal Antibody Neutralization ResistanceSemantic proximity Read ↗

Identifying immunologically-vulnerable regions of the HCV E2 glycoprotein and broadly neutralizing antibodies that target themSemantic proximity Read ↗

Development and characterization of a human monoclonal antibody targeting the N-terminal region of hepatitis C virus envelope glycoprotein E1.Semantic proximity Read ↗

Isolation and Characterization of Broadly Neutralizing Human Monoclonal Antibodies to the E1 Glycoprotein of Hepatitis C VirusSemantic proximity Read ↗

Hepatitis C Virus E1E2 Structure, Diversity, and Implications for Vaccine DevelopmentSemantic proximity Read ↗

Structural and genetic signatures of two classes of HCV E2 neutralizing face antibodies from non-human primates immunized with a recombinant E1E2Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.